SEC Form 4 · accession 0001638599-18-000697
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen A Hill
Director
Period of report
Jun 27, 2018
Accepted (ET)
Jun 28, 2018 · 12:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.33 | Jun 27, 2018 | A | 20,000 | A | Jun 27, 2019 | Jun 27, 2028 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1100% vesting one year from date of grant